Medicine and Dentistry
Transitional Cell Carcinoma
85%
Prostate Cancer
64%
Biopsy Technique
55%
Bladder Cancer
55%
Prostate Biopsy
47%
Neoplasm
41%
Quality of Life
40%
Blood Flow
35%
Infection
35%
Transrectal Ultrasonography
32%
Bladder
32%
Diseases
29%
Upper Urinary Tract
29%
Cancer Diagnosis
26%
Cystectomy
26%
Cancer
26%
Percutaneous Nephrolithotomy
23%
Cohort Analysis
23%
Clinical Significance
23%
Urologist
23%
Prostate Specific Antigen
18%
Recurrence Free Survival
18%
Disease Exacerbation
16%
Overall Survival
16%
Hazard Ratio
15%
Non Muscle Invasive Bladder Cancer
14%
Clinician
14%
Muscle Invasive Bladder Cancer
14%
Hypoxia
13%
Echography
13%
Superficial Bladder Cancer
13%
Univariate Analysis
13%
Urinary Retention
12%
Clinical Trial
12%
Metastatic Carcinoma
12%
Resistive Index
12%
Multivariate Analysis
12%
Proportional Hazards Model
11%
Immunohistochemistry
11%
Prostate Carcinoma
11%
Prostate Tumor
11%
Dendritic Cell
11%
Catheter Removal
11%
Meta-Analysis
11%
Clinical Study
11%
Uric Acid Stone
11%
Bladder Stone
11%
Interleukin 12
11%
Diagnostic Performance
11%
Single Chain Fragment Variable Antibody
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Transitional Cell Carcinoma
99%
Neoplasm
90%
Prostate Cancer
65%
Bladder Tumor
29%
Chemotherapy
25%
Cisplatin
24%
CD8 Antigen
23%
Prothymosin Alpha
23%
Phthalic Acid
23%
Tumor Suppressor Protein
17%
Recurrence Free Survival
16%
Progression Free Survival
16%
Disease Exacerbation
15%
Androgen
15%
Diseases
15%
Carcinogenesis
15%
Recurrent Disease
14%
Primary Tumor
14%
Cancer Growth
13%
Malignant Neoplasm
13%
Terazosin
11%
Biological Marker
11%
Prostate Carcinoma
11%
Magnetic Nanoparticle
11%
Interferon
11%
Single Chain Fragment Variable Antibody
11%
Squash
11%
Antitumor Activity
11%
Transcription Factor Nrf2
11%
Interleukin 12
11%
Arsenic Acid
11%
Urethra Carcinoma
11%
Short Hairpin RNA
11%
Epirubicin
11%
Vinblastine
11%
Sex Hormone
11%
Methotrexate
11%
Hypoxia
11%
Chemical Carcinogenesis
11%
Growth Differentiation Factor 15
11%
Nuclear Matrix Protein 22
11%
Tumor Marker
11%
Angiopoietin
11%
microRNA
11%
Long Untranslated RNA
11%
Renal Cell Carcinoma
11%
Iron Oxide Nanoparticle
11%
Oncolytic Adenovirus
11%
Gammaretrovirus
11%
Keyphrases
Bladder Cancer
26%
Prostate Biopsy
23%
Incremental Neural Network
23%
Prostate
23%
End-diastolic Velocity
21%
Androgen Receptor Antagonist
15%
Post-biopsy Infections
13%
MBT-2
12%
Cancer Patients
12%
Terazosin Hydrochloride
11%
Terazosin
11%
Ultrasound Image
11%
Needle Tip
11%
Urological Malignancies
11%
Clinical Frailty Scale
11%
Prostate Segmentation
11%
Tyrosine Kinase Oncogene
11%
Bladder Stone
11%
Mass Spectrometric Studies
11%
Survival Analysis
11%
Febrile Infection
11%
Non-coding RNA (ncRNA)
11%
Electrogene Transfer
11%
SMARCB1
11%
Rhabdoid Features
11%
Pumpkin Seed Oil
11%
DAB2IP
11%
Homeostatic Factor
11%
Prostate Growth
11%
HOX Transcript Antisense RNA (HOTAIR)
11%
Protein Conformational Change
11%
Male Lower Urinary Tract Symptoms
11%
Flow Information
11%
INI1
11%
Antibiotic Selection
11%
Histomorphometric Analysis
11%
Urinary Bladder Cancer
11%
HER2 Expression
11%
Dynamic MRI
11%
Signaling Axis
11%
Personalized Therapy
11%
Primary Urethral Carcinoma
11%
ZEB2
11%
Transurethral Microwave Thermotherapy
11%
Collagen Content
11%
Short-term Experience
11%
Upper Urinary Tract
11%
Ureteroscopic
11%
Percutaneous Nephrolithotomy
11%
Renal Staghorn Stones
11%
